ARIPIPRAZOLE LONG-ACTING INJECTION (Abilify Maintena®)

Clinical Indication

Maintenance treatment of schizophrenia in patients currently stabilised on oral aripiprazole

Comments

Full SCA

Date of classification

October 2005

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.